Blog
England's Reid wins in Turkey
England’s Melissa Reid led from start to finish to secure her fifth Ladies European Tour title at the Turkish Airlines Ladies Open.
Straight to Ascot for Rizeena
Rizeena will attempt to take her 100 per cent record at Ascot to four when she goes for the Duke of Cambridge Stakes at the Royal meeting next month.
Exciting times for Roberts
Jamie Roberts is already eagerly looking forward to next season with club and country after his move to Harlequins was confirmed on Tuesday.
Futures of Claude Julien, Milan Lucic top new Bruins GM Don Sweeney to-do list
Mallory Edens has perfect response to lecherous NBA Draft Lottery column
Buick Steps on the (Natural) Gas: Regal Could Be Getting Factory CNG Power
–––––––––––––––––––––––––––––––––––––––––—
2018 Golf R400 Spied on the ’Ring, Appears to Be Moving Closer to Production
-What It Is: Handily, Volkswagen has taken most of the guesswork out of deciphering just what the Golf R400 is and put it right there in the name. It’s an all-wheel-drive Golf with a worked-over 2.0T engine churning out somewhere in the neighborhood of 400 horsepower. READ MORE ›› –
2018 Volkswagen Golf R400 Spied Ringing the Nürburgring – Future Cars
–––––––––––––––––––––––––—
Gilead patents on costly hepatitis C drug challenged in five countries
By Brendan Pierson NEW YORK (Reuters) – A U.S. group is trying to block patents in five countries for Gilead Sciences Inc’s costly hepatitis C drug Sovaldi, in a bid to give almost 60 million afflicted people access to cheaper generic versions. In Argentina, Brazil, China, Russia and Ukraine, challenges have been filed against Gilead’s patents or patent applications, the New York-based Initiative for Medicines, Access & Knowledge, or I-MAK,